About: NanOlogy
Profile:
Posts by NanOlogy:
- Drug Delivery: NanOlogy looks to transform chemotherapy with localized delivery platform (March 5, 2018 - NanOlogy in the News)
- Drug Development: NanOlogy Submicron Particle Platform Transforms Systemic Chemotherapy Into Local Delivery (February 28, 2018 - NanOlogy in the News)
- DermWire: NanOlogy Enrolls First Patient in Clinical Trial for Cutaneous Metastases (February 14, 2018 - NanOlogy in the News)
- NanOlogy Announces First Patient Enrolled in a Phase 2 Clinical Trial for Cutaneous Metastases and DFB Soria Provides an Update on AK Trial (February 14, 2018 - NanOlogy Press Release, Soria)
- Houston Business Journal: NanOlogy to Update Clinical Program at BIO CEO Conference (February 5, 2018 - NanOlogy in the News)
- NanOlogy to Update Clinical Program Transforming Treatment of Cancer at BIO CEO and Investor Conference (February 5, 2018 - NanOlogy Press Release, Soria)
- NanOlogy General Presentation (Jan 2018) (January 9, 2018 - Publications)
- PharmaVOICE: Next-Generation Nanomedicines (January 3, 2018 - NanOlogy in the News)
- NanOlogy to Present Update on Cancer Treatment Clinical Program at Biotech Showcase in San Francisco (January 3, 2018 - NanOlogy Press Release, Soria)
- Drug Delivery Business: NanOlogy takes nanoparticle tech into Phase II trials (December 19, 2017 - NanOlogy in the News)
- NanOlogy Announces First Patient Enrolled in a Pancreatic Cancer Phase 2 Clinical Trial of NanoPac® Adding to Trials in Prostate and Ovarian Cancers (December 18, 2017 - NanOlogy Press Release, Soria)
- Clinical Leader: Trial Aims To Kill Cancer Without Chemotherapy Side Effects (November 20, 2017 - NanOlogy in the News)
- DDNEWS: New Cancer Answer (November 13, 2017 - NanOlogy in the News)
- NanOlogy Announces First Patient Enrolled in a Phase 2 Clinical Trial of NanoPac® for Treatment of Mucinous Cysts of the Pancreas (November 7, 2017 - NanOlogy Press Release, Soria)
- Ovarian Cancer News: First Patient Enrolled in NanoPac Trial Evaluating New Anti-Cancer Treatment Delivery (October 16, 2017 - NanOlogy in the News)
- Journal for Clinical Studies: NanOlogy begins NanoPac’s phase 2 study to treat ovarian cancer (October 16, 2017 - NanOlogy in the News)
- Drug Delivery: NanOlogy takes nanoparticle tech into phase 2 trials. (October 16, 2017 - NanOlogy in the News)
- NanOlogy Announces First Patient Enrolled in a Phase 2 Clinical Trial of NanoPac® for Treatment of Prostate Cancer (October 16, 2017 - NanOlogy Press Release, Soria)
